Aetion Evidence Platform has been tremendous for us with regards to delivering RWE more efficiently. From an operational perspective, it has helped us generate high quality evidence faster, and allows us to deliver more for our stakeholders.

The most intriguing part of the Aetion story is the ability to have a very consistent analytic approach that can be applied across multiple data sets.

Aetion’s rapid turn-around time is critical, as is the fact that their analyses are based on our membership. By using predictive modeling to identify high-risk patients—who will become high-cost—we’re able to quickly engage with providers and health systems to intervene early. This improves outcomes for our highest-risk patient populations.

As part of our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics. The Aetion Evidence Platform has helped reduce the completion time for UCB’s RWE initiatives by 50%, and has enhanced our capabilities to run multiple concurrent studies.